Vimarsana
Biggest News Aggregation in the World

Page 43 - Nasdaq First News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq First Today - Breaking & Trending Today

Scientific Reports Publishes INFORAAA Results - Vimarsana News

Scientific Reports Publishes INFORAAA Results

/PRNewswire/ -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of...

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Juho Jalkanen Appointed Chief Operating Officer - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Juho Jalkanen Appointed Chief Operating Officer

Investegate announcements from Faron Pharma. Oy, Juho Jalkanen Appointed Chief Operating Officer

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron at Proactive One2One Investor Forum - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron at Proactive One2One Investor Forum

Investegate announcements from Faron Pharma. Oy, Faron at Proactive One2One Investor Forum

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron to Present at Redeye Fight Cancer Seminar - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Faron to Present at Redeye Fight Cancer Seminar

Investegate announcements from Faron Pharma. Oy, Faron to Present at Redeye Fight Cancer Seminar

Enzymatica AB: Enzymatica comments on wrongful wording in Dagens Medicin - Vimarsana News

Enzymatica AB: Enzymatica comments on wrongful wording in Dagens Medicin

STOCKHOLM, Jan. 12, 2022 /PRNewswire/ -- The headline and introduction of an article today on the webpage of the Swedish magazine Dagens Medicin wrongfully claim that a study on ColdZyme has